In Bacterial infections Satrogyl 500mg Tablet is an antibiotic medicine that can be used to treat many different infections caused by bacteria. These include infections of the liver, stomach, intestines, vagina, brain, heart, lungs, bones, and skin. It works by stopping the growth of the bacteria causing the infection. This medicine usually makes you feel better quite quickly. However, you should continue taking it as long as it is prescribed even if you feel better, to make sure that all bacteria are killed and do not become resistant. In Parasitic infections Satrogyl 500mg Tablet helps treat many parasitic infections by stopping the growth of parasites causing the infection. Keep using this medicine for as long as it is prescribed to make sure that all the parasites are killed. Any parasites that survive may become resistant to this medicine so it will not be as effective in the future.
Consuming alcohol while taking Satrogyl 500mg Tablet may cause symptoms such as flushing, increased heart beat, nausea, thirst, chest pain and low blood pressure (Disulfiram reaction).
Information regarding the use of Satrogyl 500mg Tablet during pregnancy is not available. Please consult your doctor.
Satrogyl 500mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Satrogyl 500mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Satrogyl 500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Satrogyl 500mg Tablet may be needed. Please consult your doctor.
Satrogyl 500mg Tablet is safe to use in patients with liver disease. No dose adjustment of Satrogyl 500mg Tablet is recommended.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More